• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK SOLUTION ADMINISTRATION SETS; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK SOLUTION ADMINISTRATION SETS; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2C8671
Device Problem Free or Unrestricted Flow (2945)
Patient Problem High Blood Pressure/ Hypertension (1908)
Event Date 04/18/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that during patient infusion of levophed, phenylephrine and amiodarone with 3 units of clearlink system extension sets, an inadvertent bolus from the extension filter was observed.This resulted in the patient experiencing hypertension reported as ¿caused the blood pressure to skyrocket¿.According to the reporter, the filter emptied out on its own.No connection issues were noted and the lines were setup properly.After the "filters were removed, the patient's blood pressure "evened out".No additional information is available.
 
Manufacturer Narrative
The actual device was not available; however, a companion sample was received for evaluation.Visual inspection with the naked eye of the companion sample did not identify any abnormalities that could have contributed to the reported condition.Functional testing including clear passage and under water pressure testing were performed.The companion samples were determined to meet functional performance specification requirements.The reported condition was not verified.The cause of the condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK SOLUTION ADMINISTRATION SETS
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - CARTAGO
see h10
cartago 30106
CS   30106
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key14339574
MDR Text Key291239214
Report Number1416980-2022-02326
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00085412046334
UDI-Public(01)00085412046334
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K153158
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number2C8671
Device Lot NumberR20H06113
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/16/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/08/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AMIODARONE; LEVOPHED; PHENYLEPHRINE
Patient Outcome(s) Other;
-
-